Table 2 The distribution and clinical characteristics of 239 subjects
Fibrosis (F1-F3) | Cirrhosis (F4) | |
|---|---|---|
Age (median/range) | 45(30–63) | 47(26–59) |
Gender (F/M) | 62/117 | 15/45 |
Post-hepatitis B | 128 | 42 |
Post-hepatitis C | 51 | 18 |
Training group | 146 | 33 |
Validating group | 33 | 27 |
Training Group | Validating Group | |
Age (median/range) | 43(35–57) | 45(26–63) |
Gender (F/M) | 57/121 | 20/51 |
Post-hepatitis B | 120 | 50 |
Post-hepatitis C | 62 | 7 |
Stage of Liver Fibrosis | ||
F1 | 40 | 13 |
F2 | 22 | 8 |
F3 | 55 | 19 |
F4 | 62 | 20 |